• Explore /
  • Poster
  • / Preclinical evaluation of AMG 160, a next-generation bispecific T cell engager (BiTE) targeting the prostate-specific membrane antigen PSMA for metastatic castration-resistant prostate cancer (mCRPC).

Preclinical evaluation of AMG 160, a next-generation bispecific T cell engager (BiTE) targeting the prostate-specific membrane antigen PSMA for metastatic castration-resistant prostate cancer (mCRPC).

Abstract Poster

Authors

null

Julie Bailis

Amgen Research, South San Francisco, CA

Julie Bailis , Petra Deegen , Oliver Thomas , Pamela Bogner , Joachim Wahl , Mike Liao , Shyun Li , Katja Matthes , Virginie Nägele , Doris Rau , Benno Rattel , Tobias Raum , Peter Kufer , Angela Coxon

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, Testicular, and Adrenal Cancers

Sub Track

Prostate Cancer - Advanced Disease

Citation

J Clin Oncol 37, 2019 (suppl 7S; abstr 301)

DOI

10.1200/JCO.2019.37.7_suppl.301

Abstract #

301

Poster Bd #

D9

Abstract Disclosures

Similar Posters

First Author: Katherine L. Paweletz

Poster

2024 ASCO Genitourinary Cancers Symposium

Predictors of PSA response to Lu177-PSMA-617 in metastatic castration-resistant prostate cancer.

Predictors of PSA response to Lu177-PSMA-617 in metastatic castration-resistant prostate cancer.

First Author: Rebecca Hassoun

First Author: A. Oliver Sartor

First Author: Sumit Kumar Subudhi